Searchable abstracts of presentations at key conferences in endocrinology
Previous issue | Volume 72 | UKINETS2020

UKI NETS 18th National Conference

Poster Presentations

(1)

Post-operative NETest scores detect residual NET disease and accurately predicts tumor recurrence in R0
1Yale University, New Haven, Connecticut, USA; 2Wren Laboratories, Branford, Connecticut, USA; 3University Hospital, Uppsala, Sweden; 4San Rafaelle IRCCS, Milan, Italy; 5University of Torino, Turin, Italy; 6Imperial College, London, UK; 7Medical University of Silesia, Katowice, Poland; 8Royal Free Hospital, London, UK; 9Memorial Sloan Kettering Cancer Center, New York, USA
ea0072p1
Telotristat in the management of Carcinoid diarrhoea - real world experience of patients from an ENETs centre of excellence in Neuroendocrine tumours.
1Institute of Liver Sciences, Kings College Hospital, London, UK; 2Liver Unit, Queen Elizabeth Hospital, Birmingham, UK; 3Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, UK; 4University Hospitals Birmingham, Birmingham, UK; 5Institute of Immunology and Immunotherapy, Birmingham University, Birmingham, UK
ea0072p4
Allelic deletion of chromosome 18 is common in intra-abdominal neuroendocrine neoplasms
1University of Leicester, Leicester, UK; 2University Hospitals of Leicester NHS Trust, Leicester, UK
ea0072p5
Metachronous neuroendocrine neoplasms in England 2013-2015
1Hampshire Hospitals NHS Foundation Trust, Basingstoke, UK; 2Public Health England, London, UK; 3Neuroendocrine Cancer UK, Leamington Spa, UK; 4King's College London, London, UK
ea0072p6
Carcinoid heart surgery: Review of outcomes from a single large centre
1King's College Hospital, London, UK; 2King's College London, London, UK
ea0072p7
The prevalence of depression and anxiety among neuroendocrine tumour and general gastroenterology outpatients and the psychometric validity of emotional thermometers
1Department of Psychology, University of South Wales, Cardiff, UK; 2Department of Gastroenterology, University Hospital of Wales, Cardiff, UK; 3Department of Clinical Psychology, University Hospital of Wales, Cardiff, UK; 4Deparment of Liaison Psychiatry, University Hospital of Wales, Cardiff, UK
ea0072p8
Are outcomes of patients with advanced well-differentiated GEP-NETs on somatostatin analogues similar, irrespective of tracer uptake on 68gallium DOTA SSTR peptide PET CT scans?
1Medical Oncology, The Christie NHS Foundation Trust, Manchester, UK; 2Nuclear Medicine, The Christie NHS Foundation Trust, Manchester, UK; 3Division of Cancer Sciences, University of Manchester, Manchester, UK
ea0072p10
Effective multimodality therapy for a metastatic insulin-secreting pancreatic neuroendocrine tumour (NET): A case report
1King’s Health Partners ENETS Centre of Excellence, Department of Medical Oncology, Guy’s and St Thomas’ NHS Foundation Trust, London, UK; 2Institute of Liver Studies, King’s College Hospital NHS Foundation Trust, London, UK; 3Department of Endocrinology, Guy’s and St Thomas’ NHS Foundation Trust, London, UK; 4School of Cancer and Pharmaceutical Sciences, King’s College London, London, UK
ea0072p14
Mixed neuroendocrine-non-endocrine neoplasms (MiNEN): A case of pancreatic acinar - neuroendocrine carcinoma of large cell type
1King’s Health Partners ENETS Centre of Excellence, Department of Medical Oncology, Guy’s Hospital, London, UK; 2Institute of Liver Studies, King’s College Hospital, London, UK; 3School of Cancer and Pharmaceutical Sciences, King’s College London, London, UK
ea0072p16